| Jonathan M Loetscher, CRNA | |
|
1801 W 40th Ave, Suite 2b, Pine Bluff, AR 71603-6940 | |
| (870) 535-7457 | |
| (870) 535-2522 |
| Full Name | Jonathan M Loetscher |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 17 Years |
| Location | 1801 W 40th Ave, Pine Bluff, Arkansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073712782 | NPI | - | NPPES |
| P00428045 | Other | RR MCR | |
| 5A486 | Other | AR | BCBS |
| 165921001 | Medicaid | AR | |
| 432710240 | Other | PGBA TRICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | C02665 (Arkansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Jefferson Regional Medical Center | Pine bluff, AR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Jefferson Regional Anesthesia Llc | 6204171846 | 17 |
News Archive
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
In recent years, U.S. Food and Drug Administration reports of adverse events related to drugs have increased dramatically.
A new drug for diabetes from Bristol-Myers Squibb Co. and AstraZeneca PLC was effective in lowering blood sugar. The pharmaceutical drug makers are looking for approval for the drug, dapagliflozin, as the first in new class of pills designed to lower blood sugar by increasing the amount of glucose excreted in the urine.
In a study of college athletes in the United States it has been discovered that many of them displayed the signs of exercise-induced asthma.
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
› Verified 6 days ago
| Entity Name | Ouachita County Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346354826 PECOS PAC ID: 4587641055 Enrollment ID: O20080813000469 |
News Archive
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
In recent years, U.S. Food and Drug Administration reports of adverse events related to drugs have increased dramatically.
A new drug for diabetes from Bristol-Myers Squibb Co. and AstraZeneca PLC was effective in lowering blood sugar. The pharmaceutical drug makers are looking for approval for the drug, dapagliflozin, as the first in new class of pills designed to lower blood sugar by increasing the amount of glucose excreted in the urine.
In a study of college athletes in the United States it has been discovered that many of them displayed the signs of exercise-induced asthma.
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
› Verified 6 days ago
| Entity Name | Premier Anesthesia Of Arkansas Professional Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932519485 PECOS PAC ID: 6406077460 Enrollment ID: O20141016002060 |
News Archive
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
In recent years, U.S. Food and Drug Administration reports of adverse events related to drugs have increased dramatically.
A new drug for diabetes from Bristol-Myers Squibb Co. and AstraZeneca PLC was effective in lowering blood sugar. The pharmaceutical drug makers are looking for approval for the drug, dapagliflozin, as the first in new class of pills designed to lower blood sugar by increasing the amount of glucose excreted in the urine.
In a study of college athletes in the United States it has been discovered that many of them displayed the signs of exercise-induced asthma.
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
› Verified 6 days ago
| Entity Name | Asc Anesthesia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336509819 PECOS PAC ID: 0446558134 Enrollment ID: O20160413001033 |
News Archive
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
In recent years, U.S. Food and Drug Administration reports of adverse events related to drugs have increased dramatically.
A new drug for diabetes from Bristol-Myers Squibb Co. and AstraZeneca PLC was effective in lowering blood sugar. The pharmaceutical drug makers are looking for approval for the drug, dapagliflozin, as the first in new class of pills designed to lower blood sugar by increasing the amount of glucose excreted in the urine.
In a study of college athletes in the United States it has been discovered that many of them displayed the signs of exercise-induced asthma.
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
› Verified 6 days ago
| Entity Name | Jefferson Regional Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205301587 PECOS PAC ID: 6204171846 Enrollment ID: O20181231000163 |
News Archive
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
In recent years, U.S. Food and Drug Administration reports of adverse events related to drugs have increased dramatically.
A new drug for diabetes from Bristol-Myers Squibb Co. and AstraZeneca PLC was effective in lowering blood sugar. The pharmaceutical drug makers are looking for approval for the drug, dapagliflozin, as the first in new class of pills designed to lower blood sugar by increasing the amount of glucose excreted in the urine.
In a study of college athletes in the United States it has been discovered that many of them displayed the signs of exercise-induced asthma.
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan M Loetscher, CRNA 1801 W 40th Ave, Suite 2b, Pine Bluff, AR 71603-6940 Ph: (870) 535-7457 | Jonathan M Loetscher, CRNA 1801 W 40th Ave, Suite 2b, Pine Bluff, AR 71603-6940 Ph: (870) 535-7457 |
News Archive
A plastic surgery research group has developed an augmented reality system that enables them to create 3D simulations of the desired results of facial reconstructive procedures and project them over the patient's face during surgery, reports a study in Plastic and Reconstructive Surgery-Global Open, the official open-access medical journal of the American Society of Plastic Surgeons.
In recent years, U.S. Food and Drug Administration reports of adverse events related to drugs have increased dramatically.
A new drug for diabetes from Bristol-Myers Squibb Co. and AstraZeneca PLC was effective in lowering blood sugar. The pharmaceutical drug makers are looking for approval for the drug, dapagliflozin, as the first in new class of pills designed to lower blood sugar by increasing the amount of glucose excreted in the urine.
In a study of college athletes in the United States it has been discovered that many of them displayed the signs of exercise-induced asthma.
MMI-USA, a subsidiary of Memometal Technologies S.A., France, a global leader in the manufacture and development of extremity orthopedics, announced today the expansion of its U.S. and worldwide patent and trademark programs. Memometal recognizes the value of its intellectual property and is committed to protecting its products through aggressive procurement and enforcement of patent and trademark rights.
› Verified 6 days ago
Gary W Manly, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1801 W 40th Ave, Ste 2b, Pine Bluff, AR 71603 Phone: 870-535-7457 Fax: 870-535-2522 | |
Jason Bobo, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 3302 Shamrock Dr, Pine Bluff, AR 71603 Phone: 870-489-4864 | |
Jon C Valentine, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 1801 W 40th Ave, Ste 2b, Pine Bluff, AR 71603 Phone: 870-535-7457 Fax: 870-535-2522 | |
Walter P Theriot, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1801 W 40th Ave, Ste 2b, Pine Bluff, AR 71603 Phone: 870-535-7457 Fax: 870-535-2522 | |
James C Rassier, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1801 W 40th Ave, Ste 2b, Pine Bluff, AR 71603 Phone: 870-535-7457 Fax: 870-535-2522 | |
Mr. Nicholas Holloway, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1801 W 40th Ave, Suite 2b, Pine Bluff, AR 71603 Phone: 870-535-7457 Fax: 870-535-2522 |